Your basic understanding of IBX's technology is way off the mark (don't get me started on the antibody theory).
IBX's test is NOT designed as a screening test. We aren't designing some pan-cancer nanomolecule. Not every female will get a MRI using IBX's nanoparticles instead of a mammogram, nor a female who detects a breast lump. They will go down the same diagnosis pathway as before - usually ultrasound then biopsy. If they then received a diagnosis of HER2 positive breast cancer then they may get a MRI + nanoparticle scan to look for lymph node spread. The nanoparticle is highly specific for that type of cancer only, and wouldn't create a signal at other types of cancer.
- Forums
- ASX - By Stock
- IBX
- Ann: Imagion to complete the MagSense HER2 Phase 1 Study
Ann: Imagion to complete the MagSense HER2 Phase 1 Study, page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.7¢ |
Change
-0.009(19.6%) |
Mkt cap ! $1.318M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 3.6¢ | $11.75K | 288.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27621 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 7319 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 54667 | 0.037 |
5 | 242437 | 0.036 |
3 | 120571 | 0.035 |
1 | 20000 | 0.034 |
1 | 18750 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 11682 | 1 |
0.042 | 205207 | 1 |
0.048 | 13016 | 2 |
0.050 | 155 | 1 |
0.055 | 88714 | 1 |
Last trade - 12.36pm 03/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |